Clinical Research Management announced it is changing its name to ClinicalRM to support the company’s strategic business growth and to better differentiate itself among providers of clinical trial and research services for both pharmaceuticals and medical devices.
In conjunction with the name change, ClinicalRM is also launching a new website designed to increase communication to sponsors and partners regarding their range of capabilities and sponsor services.
When asked about a name change, Victoria Tifft, CEO and Founder of ClinicalRM responded, “When we started our business nearly two decades ago, Web URLs and e-mail addresses had very little to do with an identity. Since then, the world has come to rely on your web identity as your corporate identify. In this day and age, we need to make it easy for our prospective clients to find us and hear the ClinicalRM story.”
When asked “Why now?” Ms. Tifft described the growth strategies put in place to proactively add new customers to its long list of satisfied clients. “After years of organic growth, our board decided to take a more proactive position on growth. Understanding who you are, where you’ve been, and where you are headed is crucial to executing a growth strategy."
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.